Home > Insider Trading > Filing (0001209191-15-020552)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1011835	Medivation Inc.	MDVN	Pharmaceutical Preparations (2834)	133863260

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1206977	E Kathryn Falberg	11388 Sorrento Valley Road San Diego CA 92121		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-02-27	3,400	$116.51	3,400	No	4	P	Indirect	By Trust
Common Stock	Acquisiton	2015-02-27	19,400	$117.76	22,800	No	4	P	Indirect	By Trust
Common Stock	Acquisiton	2015-02-27	1,400	$118.37	24,200	No	4	P	Indirect	By Trust
Common Stock	Acquisiton	2015-02-27	800	$119.11	25,000	No	4	P	Indirect	By Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Trust
No	4	P	Indirect	By Trust
No	4	P	Indirect	By Trust
No	4	P	Indirect	By Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	13,307	Direct

Footnotes

The shares were purchased at prices ranging from $116.05 to $116.89. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price.
The shares were purchased at prices ranging from $117.04 to $118.01. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price.
The shares were purchased at prices ranging from $118.07 to $118.82. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price.
The shares were purchased at prices ranging from $119.00 to $119.45. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price.